Details for New Drug Application (NDA): 084566
✉ Email this page to a colleague
NDA 084566 describes LUFYLLIN, which is a drug marketed by Norvium Bioscience and is included in one NDA. Additional details are available on the LUFYLLIN profile page.
The generic ingredient in LUFYLLIN is dyphylline. There are two drug master file entries for this compound. Additional details are available on the dyphylline profile page.
The generic ingredient in LUFYLLIN is dyphylline. There are two drug master file entries for this compound. Additional details are available on the dyphylline profile page.
Summary for 084566
| Tradename: | LUFYLLIN |
| Applicant: | Norvium Bioscience |
| Ingredient: | dyphylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 084566
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
